World of Medicine and Biology is a leading academic journal dedicated to advancing the frontiers of medical and biological sciences. Published by the Scientific Society of Anatomists, Histologists & Embryologists in Ukraine, this journal provides a collaborative platform for researchers, professionals, and students to disseminate original research, critical reviews, and insightful discussions on a wide array of topics in these dynamic fields. With the ISSN 2079-8334, the journal aspires to bridge the gap between theory and practice, focusing on innovative methodologies, latest findings, and the relevance of biology to human health. Although the journal operates under a traditional access model, it ensures comprehensive reach through various indexing services and databases, solidifying its importance in the realm of scientific inquiry. As the field continues to evolve with new discoveries and technologies, the World of Medicine and Biology remains committed to fostering academic excellence and supporting the global research community in their endeavors.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

Current Issues in Pharmacy and Medical Sciences is a prominent open-access journal published by SCIENDO, dedicated to advancing knowledge and understanding in the fields of pharmacy, biochemistry, molecular biology, and medicine. With an ISSN of 2084-980X and an E-ISSN of 2300-6676, this journal provides a platform for researchers and academics to disseminate current findings and methodologies shaping the future of these disciplines. Since its inception in 2012 and having established itself as an open-access journal since 2014, Current Issues in Pharmacy and Medical Sciences has been committed to providing high-quality, peer-reviewed content that fosters innovation and scholarly collaboration, even as it currently ranks in the Q4 category across several key areas, including Pharmacology and Biochemistry. The journal's findings are particularly relevant to professionals and students aiming to stay abreast of the latest trends and issues impacting healthcare and pharmaceutical sciences. With future issues anticipated until 2024, this journal is positioned as a vital resource for anyone engaged in the pharmaceutical and medical fields and contributing to meaningful advancements.

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.

Simulation in Healthcare - Journal of the Society for Simulation in Healthcare, published by Lippincott Williams & Wilkins, is a leading journal dedicated to the advancing field of simulation science within healthcare. With an ISSN of 1559-2332 and an E-ISSN of 1559-713X, it serves as a vital platform for researchers, practitioners, and educators to disseminate innovative findings and methodologies related to simulation-based learning and assessment in healthcare settings. The journal, which spans from 2006 to 2024, holds a notable presence in various academic quartiles: Q2 in Education and Modeling and Simulation, and Q3 in Epidemiology and Medicine (miscellaneous), showcasing its broad impact across interdisciplinary domains. With SCOPUS rankings placing it in the 74th percentile for Social Sciences and Education, and maintaining robust contributions to the advancement of medical training, this journal is indispensable for those seeking evidence-based practices and cutting-edge knowledge in simulation methodologies. Although it does not operate under an Open Access model, subscriptions provide vital access to its high-quality content, making it an essential resource for enhancing educational and clinical practices in healthcare.

Journal of Patient Safety and Risk Management, published by SAGE Publications Ltd, stands as a vital resource for the exploration and discourse surrounding safety and risk in healthcare environments. Established in 2018 and continuing through 2024, this journal delivers a rich repository of knowledge aimed at improving patient safety protocols and mitigating risks within healthcare systems. With an ISSN of 2516-0435 and an E-ISSN of 2516-0443, the journal is indexed in several categories with a notable performance in Health Policy and Health (social science), rated in Q3, while also addressing Leadership and Management in Q4. Despite the absence of an open access model, the journal provides a platform for researchers, healthcare professionals, and students to stay informed about the latest developments and evidence-based practices within the dynamically evolving landscape of patient safety. Given its Scopus rankings, which include a percentile of 46th in Health (social science) and 36th in Health Policy, the journal is positioned as a credible and impactful publication for those dedicated to enhancing patient care through robust risk management strategies.

Physical and Engineering Sciences in Medicine is an esteemed peer-reviewed journal published by SPRINGER, dedicated to advancing the interdisciplinary fields of biomedical engineering and biophysics. With an ISSN of 2662-4729 and an E-ISSN of 2662-4737, this journal has carved a niche for itself since its inception in 2020. Situated in the Netherlands, it serves as a global platform for innovative research and developments that bridge the physical sciences and engineering with medical applications. The journal boasts a commendable range of quartile categorizations, highlighting its impact in various sectors including Instrumentation (Q1), Radiology (Q2), and Biotechnology (Q2). Its Scopus rankings further emphasize its relevance and quality, placing it in the top 15% in several categories. Being an Open Access title, it promotes the dissemination of knowledge, ensuring that vital research is accessible to all, thereby fostering collaboration among researchers, professionals, and students alike. The journal's objectives include promoting cutting-edge research, enhancing biomedical technology, and addressing complex health challenges through innovative engineering solutions, establishing it as a vital resource in the scientific community.

BJS Open is a premier open-access journal published by Oxford University Press, dedicated to advancing the fields of medicine and surgery. With an ISSN of 2474-9842 and an impactful presence since its inception in 2017, the journal has quickly established itself as a leading platform for innovative research, boasting a formidable Q1 ranking in both the Medicine (miscellaneous) and Surgery categories as of 2023. This makes it an invaluable resource for researchers, professionals, and students seeking to stay at the forefront of medical and surgical advancements. As an open-access publication, BJS Open ensures that cutting-edge findings are freely accessible, promoting widespread dissemination and collaboration across the global medical community. The journal's commitment to rigorously peer-reviewed content reinforces its reputation as a reliable source for high-quality research and insights. With its headquarters in Oxford, England, BJS Open continues to contribute significantly to the ongoing discourse and development in its respective fields.

Malaysian Journal of Medical Sciences, published by PENERBIT UNIVERSITI SAINS MALAYSIA, is a distinguished open-access journal dedicated to advancing knowledge in the field of medicine. With an E-ISSN of 2180-4303 and a comprehensive publication history dating back to 2003, the journal has carved out a notable presence in the academic community, achieving a Scopus rank of #198 in the General Medicine category and placing in the 68th percentile for its contributions. The journal, classified in the Q3 quartile for the year 2023, encompasses a broad spectrum of medical disciplines, providing a platform for researchers and professionals to share valuable insights and discoveries that can influence healthcare practices in Malaysia and beyond. As an open-access publication since 2017, it ensures that cutting-edge research is accessible to a wider audience, fostering collaboration and innovation in the medical sciences. Whether you are a seasoned researcher, a healthcare professional, or a dedicated student, the Malaysian Journal of Medical Sciences offers a vital resource to enhance your understanding of contemporary medical advancements.